Back to search
Primary Biliary Cholangitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Biliary Cholangitis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Biliary Cholangitis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Long-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)
This study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a p…
The study will include participants who were exposed to at least one dose of elafibranor either within the three weeks before conception or at any time during p…
The purpose of this study is to find out how well and safely elafibranor works compared to placebo in adult participants with Primary sclerosing cholangitis (PS…
The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver). PBC is a slowly progressive disease…
Randomized, double-blind, active-controlled, parallel-group study of HTD1801 in adolescents.
This is a randomized, double blind, single center, ascending single dose study to evaluate the safety, tolerability, and PK of HTD1801.